Angiogenesis in Cancers

• Andere auteurs: Ribatti, Domenico (Redacteur)
• Formaat: Elektronisch Hoofdstuk
• Taal: Engels
• Gepubliceerd in: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Onderwerpen: Medicine; Oncology; RBP4; metastasis; breast cancer; angiogenesis; endothelial dysfunction; STAT3; VEGF; endothelin-1; resveratrol; gemcitabine; endoglin; ERKs; microvessel growth; lung cancer; cancer; anticancer; DLBCL; tumor microenvironment; cell adhesion mediated drug resistance; tumor progression; VEGFR; anti-angiogenesis; anti-angiogenic agents; immunosuppression; immunotherapy; immune-checkpoint inhibitors; combination therapy; tumor angiogenesis; endothelium; microenvironment; multiple myeloma; adhesion molecules; immune-checkpoint inhibitor; tumor-derived exosomes; small extracellular vesicles; feline mammary carcinoma; VEGF-A; VEGFR-1; VEGFR-2; non-invasive biomarkers; selectins; E-selectin; uproleselan; adrenal fetal cortex; adrenocortical tumors; adrenocortical carcinoma; anti-angiogenic drugs; bFGF; anti-angiogenic therapy; resistance; vascular permeability; drug delivery system; microbeam radiation therapy (MRT); Chicken Chorioallantoic Membrane (CAM); U-87 Glioblastoma; ginsenoside Rg3; response surface methodology; optimisation; epimer; long pentraxin 3; FGF/FGFR system
• Online toegang: DOAB: download the publication; DOAB: description of the publication

Tumor progression is linked to a switch in the balance between positive and negative regulators, and mainly depends on the release by inflammatory or neoplastic cells of specific growth factors. Inflammatory infiltration contributes to tumor progression and metastatic process, and there are many rep...